pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Bosulif
drug
save

Bosulif

Marketedupdated 5mo ago
by $PFE PFIZER INC
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval94 co-mentions · 24 sources
  • drugBOSUTINIB MONOHYDRATE47 co-mentions · 24 sources
  • tagSmall Molecule47 co-mentions · 24 sources
  • drugbosutinib47 co-mentions · 24 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Bosulif

  • phase3Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIscompletedn=233
  • phase2iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Studycompletedn=46
  • phase4Asciminib Roll-over Studyrecruitingn=347
  • —A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).recruitingn=600
  • phase3A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPactive not recruitingn=405
  • phase2Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)recruitingn=720
  • phase2Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemiaactive not recruitingn=60
  • phase3Study of Olverembatinib (HQP1351) in Patients With CP-CMLrecruitingn=285

News(0)

no news has mentioned this drug yet

brand
Bosulif
generic
bosutinib
indication
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?